Fosamax is a prescription drug used in the treatment of:
- Osteoporosis
- Osteopenia
- Bone loss associated with cancer
- Paget’s disease of the bone
Fosamax is in a class of drugs known as Bisphosphonates, which are a class of bone-strengthening drugs used to inhibit bone loss. Other drugs in this class include: Aredia, Zometa, and Actonel.
Fosamax is widely prescribed to post-menopausal women for the prevention of osteoporosis. It is also prescribed to men and women for other conditions as described above.
In the past few years, Fosamax has been associated with Osteonecrosis of the Jaw (ONJ).
What is Osteonecrosis of the Jaw (ONJ)?
"Osteo" means bone and "necrosis" means cell or tissue death. Osteonecrosis is the destruction of bone tissue, frequently due to an interference with the supply of blood to the bone. It can follow a tooth extraction or other dental procedure.
- According to the American Dental Association: symptoms of "bisphosphonate-associated ONJ includes pain, soft-tissue swelling and infection, loosening of teeth, drainage, and exposed bone."
view article here »
If you have suffered osteonecrosis of the jaw and you have taken Fosamax or another bisphosphonate, you should investigate your legal rights by talking to an attorney experienced in the field of pharmaceutical litigation.
Carr & Carr attorneys have handled drug side effect cases for many years. Please call us today so that we can help you.
